Khare S, Tien X Y, Wilson D, Wali R K, Bissonnette B M, Scaglione-Sewell B, Sitrin M D, Brasitus T A
Department of Medicine, University of Chicago, Illinois 60637.
Endocrinology. 1994 Jul;135(1):277-83. doi: 10.1210/endo.135.1.7912183.
Recent studies have implicated protein kinase-C (PKC) in the regulation of guanylate cyclase in several cell types. In view of prior experiments by our laboratory which have demonstrated that 1 alpha,25-dihydroxyvitamin D3 [1 alpha,25-(OH)2D3] can activate PKC in CaCo-2 cells, it was of interest to determine whether this secosteroid influenced particulate guanylate cyclase and, if so, to determine which isoforms of PKC were involved. To address these issues, CaCo-2 cells were treated with 1 alpha,25-(OH)2D3 or other agents (see below), and crude membranes prepared from these cells were assayed for guanylate cyclase activity. In several experiments, agents were added directly to isolated membranes, and guanylate cyclase activity was then assayed. These studies demonstrated that 1) the addition of 1 alpha,25-(OH)2D3 or 12-O-tetradecanoyl phorbol 13-acetate (TPA), a known activator of PKC, to intact CaCo-2 cells stimulated particulate guanylate cyclase activity in a time- and concentration-dependent manner; 2) these agents induced the translocation of PKC alpha, but not PKC zeta, from the cytosolic to the membrane fraction of these cells; 3) preincubation of cells with staurosporine (50 nM), a PKC inhibitor, or U73122 (10 microM), an inhibitor of phospholipase-C-dependent processes, significantly reduced (P < 0.05) the stimulatory effect of 1 alpha,25-(OH)2D3 (3 nM) on guanylate cyclase; 4) preincubation of isolated membranes with TPA, calcium, and Mg(2+)-ATP increased guanylate cyclase activity, an affect that was augmented by purified rat brain PKC and inhibited by the PKC inhibitor peptide, PKC-(19-36); and 5) selective down-regulation of PKC alpha by treatment of cells with TPA (200 nM) for 24 h concomitantly abolished the activation of guanylate cyclase by 1 alpha,25-(OH)2D3. Taken together, these studies demonstrate that 1 alpha,25-(OH)2D3 activates particulate guanylate cyclase at least in part via a PKC alpha-dependent mechanism.
最近的研究表明,蛋白激酶C(PKC)在几种细胞类型中参与鸟苷酸环化酶的调节。鉴于我们实验室先前的实验已证明1α,25-二羟基维生素D3 [1α,25-(OH)2D3]可在CaCo-2细胞中激活PKC,因此确定这种甾醇是否影响颗粒性鸟苷酸环化酶以及如果有影响,确定涉及哪些PKC同工型是很有意义的。为了解决这些问题,用1α,25-(OH)2D3或其他试剂(见下文)处理CaCo-2细胞,并测定从这些细胞制备的粗膜的鸟苷酸环化酶活性。在几个实验中,将试剂直接添加到分离的膜中,然后测定鸟苷酸环化酶活性。这些研究表明:1)向完整的CaCo-2细胞中添加1α,25-(OH)2D3或12-O-十四烷酰佛波醇13-乙酸酯(TPA,一种已知的PKC激活剂)以时间和浓度依赖性方式刺激颗粒性鸟苷酸环化酶活性;2)这些试剂诱导PKCα从这些细胞的胞质溶胶向膜部分易位,但不诱导PKCζ易位;3)用PKC抑制剂星形孢菌素(50 nM)或磷脂酶C依赖性过程的抑制剂U73122(10 μM)预孵育细胞,可显著降低(P < 0.05)1α,25-(OH)2D3(3 nM)对鸟苷酸环化酶的刺激作用;4)用TPA、钙和Mg(2+)-ATP预孵育分离的膜可增加鸟苷酸环化酶活性,纯化的大鼠脑PKC可增强这种作用,而PKC抑制剂肽PKC-(19-36)可抑制这种作用;5)用TPA(